 |
| Research article summary (published 30 Jan 2003): |
|
Free Full Text! See links below |
Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance.
Full Abstract
BACKGROUND:
Serum anticholinergic activity (SAA), as measured by a radioreceptor assay, quantifies a person's overall anticholinergic burden caused by all drugs and their metabolites. In several small geriatric patient groups, SAA has been associated with cognitive impairment or frank delirium. To our knowledge, there has not yet been any systematic study of the prevalence of SAA and its effect on cognition in a community-based population.
METHODS:
Serum anticholinergic activity was measured in 201 subjects who were randomly selected among the participants in an epidemiological community study, based on their age and sex. Cognitive performance was assessed with use of the Mini-Mental State Examination. The association between SAA and cognitive performance was examined using a univariate analysis and a multiple logistic regression model, adjusting for age, sex, educational level, and number of medications.
RESULTS:
Serum anticholinergic activity was detectable in 180 (89.6%) participants (range, 0.50-5.70 pmol/mL). Univariate testing showed a significant association between SAA and Mini-Mental State Examination scores. Logistic regression analysis indicated that subjects with SAA at or above the sample's 90th percentile (ie, SAA >/=2.80 pmol/mL) were 13 times (odds ratio, 1.08-152.39) more likely than subjects with undetectable SAA to have a Mini-Mental State Examination score of 24 (the sample's 10th percentile) or below.
CONCLUSIONS:
To our knowledge, this is the largest analysis of SAA and the first to examine its extent and relationship with cognitive performance in a community sample. Its results suggest that SAA can be detected in most older persons in the community and confirm that even low SAA is associated with cognitive impairment.
Learn Faster Today Improve your study skills
Author information
Author/s: Mulsant, Benoit H (BH); Pollock, Bruce G (BG); Kirshner, Margaret (M); Shen, Changyu (C); Dodge, Hiroko (H); Ganguli, Mary (M);
Affiliation: Department of Psychiatry, University of Pittsburgh School of Medicine, PA, USA. Mulsantbh@msx.upmc.edu
Grants: AG07562 (Agency:United States NIA) ; MH01613 (Agency:United States NIMH) ; MH30915 (Agency:United States NIMH) ; MH52247 (Agency:United States NIMH) ; MH59666 (Agency:United States NIMH) ; MH64173 (Agency:United States NIMH) ; MH65416 (Agency:United States NIMH)
Journal and publication information
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
Journal: Archives of general psychiatry (Arch Gen Psychiatry), published in United States. (Language: eng)
Reference: 2003-Feb; vol 60 (issue 2) : pp 198-203
Dates: Created 2003/02/11; Completed 2003/03/04; Revised 2007/11/14;
PMID: 12578438, status: MEDLINE (last retrieval date: 11/6/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
This article has not been indexed for related articles as yet, however you can still use the live related article search links below.
See a large map of 100+ related articles.